These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4529087)

  • 1. Proceedings: Dimethyltryptamine: its biosynthesis and possible role in mental disease.
    Mandel LR
    Psychopharmacol Bull; 1974 Jul; 10(3):55-6. PubMed ID: 4529087
    [No Abstract]   [Full Text] [Related]  

  • 2. N,N-dimethyltryptamine--a possible relationship to schizophrenia?
    Wyatt RJ; Gillin JC; Kaplan J; Stillman R; Mandel L; Ahn HS; VandenHeuvel WJ; Walker RW
    Adv Biochem Psychopharmacol; 1974; 11(0):299-313. PubMed ID: 4602668
    [No Abstract]   [Full Text] [Related]  

  • 3. The biosynthesis of dimethyltryptamine in vivo.
    Mandel LR; Prasad R; Lopez-Ramos B; Walker RW
    Res Commun Chem Pathol Pharmacol; 1977 Jan; 16(1):47-58. PubMed ID: 14361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double bonds, aliphatic chains, and hallucinogens, updated.
    Abramson HA; Gettner HH
    J Asthma Res; 1979 Jul; 16(4):120. PubMed ID: 391793
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hallucinogen excretion in untreated psychiatric patients].
    Kanabus P; Krysa G; Matsumoto H
    Psychiatr Pol; 1973; 7(5):517-23. PubMed ID: 4520107
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of dimethyltryptamine biosynthesis by N,N'-bis-(3-methyl-2-thiazolidinylidene)succinamide (I) and 2-imino-3-methylthiazolidine (II).
    Mandel LR; Rokach J; Rooney CS; Cragoe EJ
    Mol Pharmacol; 1978 Sep; 14(5):930-9. PubMed ID: 280749
    [No Abstract]   [Full Text] [Related]  

  • 7. N, N-dimethyltryptamine: an endogenous hallucinogen.
    Barker SA; Monti JA; Christian ST
    Int Rev Neurobiol; 1981; 22():83-110. PubMed ID: 6792104
    [No Abstract]   [Full Text] [Related]  

  • 8. The excretion of dimethyltryptamine in psychiatric patients.
    Murray RM; Oon MC
    Proc R Soc Med; 1976 Nov; 69(11):831-2. PubMed ID: 1070023
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for and against the involvement of N,N-dimethyl-tryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in schizophrenia.
    Gillin JC; Wyatt RJ
    Psychopharmacol Bull; 1976 Oct; 12(4):12-3. PubMed ID: 1067623
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of antiserotonin on the experimental psychosis induced by dimethyltryptamine.
    SAI-HALASZ A
    Experientia; 1962 Mar; 18():137-8. PubMed ID: 14496041
    [No Abstract]   [Full Text] [Related]  

  • 11. Lack of enhancement of dimethyltryptamine formation in rat brain and rabbit lung in vivo by methionine or S-adenosylmethionine.
    Stramentinoli G; Baldessarini RJ
    J Neurochem; 1978 Oct; 31(4):1015-20. PubMed ID: 279646
    [No Abstract]   [Full Text] [Related]  

  • 12. Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis.
    Heekeren K; Neukirch A; Daumann J; Stoll M; Obradovic M; Kovar KA; Geyer MA; Gouzoulis-Mayfrank E
    J Psychopharmacol; 2007 May; 21(3):312-20. PubMed ID: 17591658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood and urine levels of N,N-dimethyltryptamine following administration of psychoactive dosages to human subjects.
    Kaplan J; Mandel LR; Stillman R; Walker RW; VandenHeuvel WJ; Gillin JC; Wyatt RJ
    Psychopharmacologia; 1974; 38(3):239-45. PubMed ID: 4607811
    [No Abstract]   [Full Text] [Related]  

  • 14. COMPARISON OF A PLACEBO, N-DIMETHYLTRYPTAMINE, AND 6-HYDROXY-N-DIMETHYLTRYPTAMINE IN MAN.
    ROSENBERG DE; ISBELL H; MINER EJ
    Psychopharmacologia; 1963 Feb; 4():39-42. PubMed ID: 14050410
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.
    Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA
    Pharmacopsychiatry; 2005 Nov; 38(6):301-11. PubMed ID: 16342002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine.
    Jacob MS; Presti DE
    Med Hypotheses; 2005; 64(5):930-7. PubMed ID: 15780487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The skeleton structure of a hallucinogenic molecule].
    Smythies JR
    Vestn Akad Med Nauk SSSR; 1969; 24(4):41-4. PubMed ID: 5346215
    [No Abstract]   [Full Text] [Related]  

  • 18. Possible source of error in studies of enzymatic formation of dimethyltryptamine.
    Rosengarten H; Meller E; Freidhoff AJ
    J Psychiatr Res; 1976; 13(1):23-30. PubMed ID: 1067427
    [No Abstract]   [Full Text] [Related]  

  • 19. DMT at fifty.
    Szára S
    Neuropsychopharmacol Hung; 2007 Dec; 9(4):201-5. PubMed ID: 18510265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic profiling in schizophrenia and major mental disorders.
    Iwamoto K; Kato T
    Neuropsychobiology; 2009; 60(1):5-11. PubMed ID: 19684418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.